Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety

Psychiatry Research

Volumn 25, Issue 1, 1988, Pages 81-90

  Johnston, Amanda L ^a   File, Sandra E ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Anxiety; panic disorder; phenelzine; triazolobenzodiazepines

Indexed keywords

8 CHLORO 1 [2 (DIMETHYLAMINO)ETHYL] 6 PHENYL 4H 1,2,4 TRIAZOLO[4,3 A][1,4]BENZODIAZEPINE TOSYLATE; ADINAZOLAM; ALPRAZOLAM; PHENELZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; DRUG THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAT; SOCIAL INTERACTION;

ADMINISTRATION, ORAL; ALPRAZOLAM; ANIMAL; AROUSAL; AVOIDANCE LEARNING; BENZODIAZEPINES; COMPARATIVE STUDY; DISCRIMINATION LEARNING; FEAR; INJECTIONS, INTRAPERITONEAL; MALE; ORIENTATION; PANIC; PHENELZINE; RATS; RATS, INBRED STRAINS; SOCIAL BEHAVIOR; SUPPORT, NON-U.S. GOV'T;

EID: 0023782875     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(88)90161-8     Document Type: Article

References (31)

1. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder
2. The elevated plus-maze test of anxiety: Further validation
3. Pharmacotherapy of the panic disorders
4. An open trial of clonazepam in the treatment of patients with recurrent panic attacks
5. Noradrenergic function and the mechanism of action of antianxiety treatment: I. The effect of long-term alprazolam treatment
6. Alprazolam: A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression
7. Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant
8. 2-adrenoceptors involved in the regulation of rat growth hormone secretion?
9. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs
10. Animal models for predicting clinical efficacy of anxiolytic drugs: Social behaviour
11. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilizers and of stimulants
12. Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat
13. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard
14. Pro- and anti-panic treatments and measures of anxiety in the rat
15. Pharmacological treatment of panic disorder
16. Medication in the treatment of panic attacks and phobic states
17. Delineation of two drug-responsive anxiety syndromes
18. Are there anticompulsive or antiphobic drugs? Review of the evidence
19. Syndromes of anxiety
20. Diezepam and propanolol in panic disorder and agoraphobia
21. Stimulant drugs enhance effects of punishment in normal and chlordiazepoxide-treated rats
22. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
23. Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex?
24. Inhibitors of monoamine oxidase and decarboxylase of aromatic amino acids
25. Panic disorders: Current perspectives
26. Current views on the treatment of panic and phobic disorders
27. U 43,465F: A benzodiazepine with antidepressant activity? Interaction with Ro 15-1788 and d,l-propranolol
28. Classification of anxiety disorders: A critique of DSM-III
29. U-43,465F: A triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals